Why Did Tesla Stock Fall So Sharply?
Tesla (TSLA) stock has often gone against the grain. It…
Sell
14
AIP Quote, Financials, Valuation and Earnings
Last price:
$5.89
Seasonality move
:
4.51%
Day range:
$5.69 - $6.43
52-week range:
$5.69 - $12.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.98x
P/B ratio:
184.43x
Volume:
280.6K
Avg. volume:
178.1K
1-year change:
-17.48%
Market cap:
$241.6M
Revenue:
$57.7M
EPS (TTM):
-$0.87
Analysts' Opinion
-
Consensus RatingArteris has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.20, Arteris has an estimated upside of 133.05% from its current price of $5.90.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $5.90.
Fair Value
-
According to the consensus of 5 analysts, Arteris has 133.05% upside to fair value with a price target of $13.20 per share.
AIP vs. S&P 500
-
Over the past 5 trading days, Arteris has underperformed the S&P 500 by -6.09% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Arteris does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arteris has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Arteris reported revenues of $15.5M.
Earnings Growth
-
Arteris has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Arteris reported earnings per share of -$0.20.
Enterprise value:
199.8M
EV / Invested capital:
--
Price / LTM sales:
3.98x
EV / EBIT:
--
EV / Revenue:
3.46x
PEG ratio (5yr expected):
-4.20x
EV / Free cash flow:
-191.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$51.8M
Return On Assets:
-33.35%
Net Income Margin (TTM):
-58.27%
Return On Equity:
-543.51%
Return On Invested Capital:
-381.39%
Operating Margin:
-45.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $50.4M | $53.7M | $57.7M | $12.5M | $15.5M | |
| Gross Profit | $46.1M | $48.6M | $51.8M | $11.1M | $13.9M | |
| Operating Income | -$28.9M | -$35.1M | -$31.6M | -$9.2M | -$7.1M | |
| EBITDA | -$25.3M | -$28.5M | -$24.8M | -$7.5M | -$5.4M | |
| Diluted EPS | -$0.84 | -$1.03 | -$0.87 | -$0.28 | -$0.20 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29M | $106.6M | $81.1M | $58.4M | $69.1M | |
| Total Assets | $42.7M | $120.4M | $115.5M | $102.8M | $106.1M | |
| Current Liabilities | $28.2M | $42.5M | $43.7M | $46.4M | $59.3M | |
| Total Liabilities | $54.7M | $67.5M | $78M | $87.7M | $107.3M | |
| Total Equity | -$12M | $52.9M | $37.5M | $15.1M | -$1.2M | |
| Total Debt | $1.9M | $1.1M | $1.7M | $3.4M | $2.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.8M | -$15.7M | -$720K | -$3M | -$2.6M | |
| Cash From Investing | -$37.5M | -$4.7M | $970K | -$1.4M | -$1.9M | |
| Cash From Financing | -$4.2M | -$2.9M | -$262K | -$584K | $414K | |
| Free Cash Flow | -$7.8M | -$17.2M | -$1M | -$3.4M | -$2.7M | |
AIP
Sector
Market Cap
$241.6M
$77.3M
Price % of 52-Week High
46.68%
52.05%
Dividend Yield
0%
0%
Shareholder Yield
--
0.76%
1-Year Price Total Return
-17.48%
-26.2%
Beta (5-Year)
--
0.881
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.79
200-day SMA
Sell
Level
$8.40
Bollinger Bands (100)
Sell
Level
7.77 - 10.71
Chaikin Money Flow
Buy
Level
12.6M
20-day SMA
Sell
Level
$7.38
Relative Strength Index (RSI14)
Sell
Level
24.28
ADX Line
Sell
Level
32.79
Williams %R
Buy
Level
-91.5663
50-day SMA
Sell
Level
$8.77
MACD (12, 26)
Sell
Level
-0.66
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
9.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2924)
Sell
CA Score
(Annual)
Level (-3.4551)
Buy
Beneish M-Score
(Annual)
Level (-3.3521)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (5.8347)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
Stock Forecast FAQ
In the current month, AIP has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AIP average analyst price target in the past 3 months is $13.20.
-
Where Will Arteris Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arteris share price will rise to $13.20 per share over the next 12 months.
-
What Do Analysts Say About Arteris?
Analysts are divided on their view about Arteris share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arteris is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Arteris's Price Target?
The price target for Arteris over the next 1-year time period is forecast to be $13.20 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AIP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arteris is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AIP?
You can purchase shares of Arteris via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arteris shares.
-
What Is The Arteris Share Price Today?
Arteris was last trading at $5.89 per share. This represents the most recent stock quote for Arteris. Yesterday, Arteris closed at $5.90 per share.
-
How To Buy Arteris Stock Online?
In order to purchase Arteris stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Nio Vs Rivian Stock, Which EV Is Best?
Nio (NYSE:NIO) and Rivian (NASDAQ:RIVN) are two EV startups that…
Is Sweetgreen Stock Worth Holding For the Next Five Years?
Sweetgreen (NYSE:SG) is an up-and-coming quick service restaurant chain focused…
Stock Ideas
Sell
31
Is AAPL Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
56
YANG alert for Apr 8
Direxion Daily FTSE China Bear 3X Shares [YANG] is up 25.64% over the past day.
Buy
51
RYTM alert for Apr 8
Rhythm Pharmaceuticals [RYTM] is up 17.23% over the past day.
Sell
49
X alert for Apr 8
United States Steel [X] is up 16.3% over the past day.
